FDA Inspection
Cardinal Health 418, Inc.Cardinal Health 418, Inc. – FDA Inspection, Feb 21, 2020
Record Details
This FDA Inspection record concerns Cardinal Health 418, Inc., with an inspection on February 21, 2020, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Cardinal Health 418, Inc.
- Inspection Date
- February 21, 2020
- Product Type
- Drugs
View Company Profile
ID · 22faefdc-3114-4145-9866-66d5e64315c9
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1118976
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
2- 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
- 21 CFR 211.100(a)Absence of Written Procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Cardinal Health 418, Inc.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| June 18, 2026 | Not classified | Denver District Office | Drug Quality Assurance |
| July 11, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 17, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Cardinal Health 418, Inc.
- FDA Inspection 1323358 - 2026-06-18
- FDA Inspection 1062692 - 2018-07-11
- FDA Inspection 883410 - 2014-06-17
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.